206 related articles for article (PubMed ID: 36004621)
21. Anlotinib attenuated bleomycin-induced pulmonary fibrosis via the TGF-β1 signalling pathway.
Ruan H; Lv Z; Liu S; Zhang L; Huang K; Gao S; Gan W; Liu X; Zhang S; Helian K; Li X; Zhou H; Yang C
J Pharm Pharmacol; 2020 Jan; 72(1):44-55. PubMed ID: 31659758
[TBL] [Abstract][Full Text] [Related]
22. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
23. Roles of high-mobility group box 1 and thrombin in murine pulmonary fibrosis and the therapeutic potential of thrombomodulin.
Kida T; Seno T; Nagahara H; Inoue T; Nakabayashi A; Kukida Y; Fujioka K; Fujii W; Wada M; Kohno M; Kawahito Y
Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L473-L483. PubMed ID: 29212801
[TBL] [Abstract][Full Text] [Related]
24. Sulforaphane attenuates pulmonary fibrosis by inhibiting the epithelial-mesenchymal transition.
Kyung SY; Kim DY; Yoon JY; Son ES; Kim YJ; Park JW; Jeong SH
BMC Pharmacol Toxicol; 2018 Apr; 19(1):13. PubMed ID: 29609658
[TBL] [Abstract][Full Text] [Related]
25. LOXL2, a copper-dependent monoamine oxidase, activates lung fibroblasts through the TGF-β/Smad pathway.
Wen X; Liu Y; Bai Y; Li M; Fu Q; Zheng Y
Int J Mol Med; 2018 Dec; 42(6):3530-3541. PubMed ID: 30320382
[TBL] [Abstract][Full Text] [Related]
26. Targeted inhibition of disheveled PDZ domain via NSC668036 depresses fibrotic process.
Wang C; Dai J; Sun Z; Shi C; Cao H; Chen X; Gu S; Li Z; Qian W; Han X
Exp Cell Res; 2015 Feb; 331(1):115-122. PubMed ID: 25445788
[TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide inhibits transforming growth factor-β1-induced fibroblast to myofibroblast differentiation in vitro and bleomycin induced lung fibrosis in vivo.
Luo F; Zhuang Y; Sides MD; Sanchez CG; Shan B; White ES; Lasky JA
Respir Res; 2014 Apr; 15(1):51. PubMed ID: 24762191
[TBL] [Abstract][Full Text] [Related]
28. Lrp5/β-Catenin Signaling Controls Lung Macrophage Differentiation and Inhibits Resolution of Fibrosis.
Sennello JA; Misharin AV; Flozak AS; Berdnikovs S; Cheresh P; Varga J; Kamp DW; Budinger GR; Gottardi CJ; Lam AP
Am J Respir Cell Mol Biol; 2017 Feb; 56(2):191-201. PubMed ID: 27668462
[TBL] [Abstract][Full Text] [Related]
29. Mitogen-activated Protein Kinase-activated Protein Kinase 2 Inhibition Attenuates Fibroblast Invasion and Severe Lung Fibrosis.
Liang J; Liu N; Liu X; Mena JM; Xie T; Geng Y; Huan C; Zhang Y; Taghavifar F; Huang G; Kurkciyan A; Barron V; Jiang D; Noble PW
Am J Respir Cell Mol Biol; 2019 Jan; 60(1):41-48. PubMed ID: 30130411
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of Wnt/β-catenin signaling suppresses myofibroblast differentiation of lung resident mesenchymal stem cells and pulmonary fibrosis.
Cao H; Wang C; Chen X; Hou J; Xiang Z; Shen Y; Han X
Sci Rep; 2018 Sep; 8(1):13644. PubMed ID: 30206265
[TBL] [Abstract][Full Text] [Related]
31. Sphingosine Kinase 1/S1P Signaling Contributes to Pulmonary Fibrosis by Activating Hippo/YAP Pathway and Mitochondrial Reactive Oxygen Species in Lung Fibroblasts.
Huang LS; Sudhadevi T; Fu P; Punathil-Kannan PK; Ebenezer DL; Ramchandran R; Putherickal V; Cheresh P; Zhou G; Ha AW; Harijith A; Kamp DW; Natarajan V
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192225
[TBL] [Abstract][Full Text] [Related]
32. Lysine-specific demethylase-1 regulates fibroblast activation in pulmonary fibrosis via TGF-β1/Smad3 pathway.
Pan X; Li J; Tu X; Wu C; Liu H; Luo Y; Dong X; Li X; Pan LL; Sun J
Pharmacol Res; 2020 Feb; 152():104592. PubMed ID: 31830521
[TBL] [Abstract][Full Text] [Related]
33. Tenofovir alafenamide fumarate attenuates bleomycin-induced pulmonary fibrosis by upregulating the NS5ATP9 and TGF-β1/Smad3 signaling pathway.
Li L; Zhao J; Zhou L; Chen J; Ma Y; Yu Y; Cheng J
Respir Res; 2019 Jul; 20(1):163. PubMed ID: 31331325
[TBL] [Abstract][Full Text] [Related]
34. Betulinic acid attenuated bleomycin-induced pulmonary fibrosis by effectively intervening Wnt/β-catenin signaling.
Li X; Liu X; Deng R; Gao S; Jiang Q; Liu R; Li H; Miao Y; Zhai Y; Zhang S; Wang Z; Ren Y; Ning W; Zhou H; Yang C
Phytomedicine; 2021 Jan; 81():153428. PubMed ID: 33341025
[TBL] [Abstract][Full Text] [Related]
35. P311 Promotes Lung Fibrosis via Stimulation of Transforming Growth Factor-β1, -β2, and -β3 Translation.
Duan FF; Barron G; Meliton A; Mutlu GM; Dulin NO; Schuger L
Am J Respir Cell Mol Biol; 2019 Feb; 60(2):221-231. PubMed ID: 30230348
[TBL] [Abstract][Full Text] [Related]
36. WNT/β-catenin signaling induces IL-1β expression by alveolar epithelial cells in pulmonary fibrosis.
Aumiller V; Balsara N; Wilhelm J; Günther A; Königshoff M
Am J Respir Cell Mol Biol; 2013 Jul; 49(1):96-104. PubMed ID: 23526221
[TBL] [Abstract][Full Text] [Related]
37. Qingfei xieding prescription ameliorates mitochondrial DNA-initiated inflammation in bleomycin-induced pulmonary fibrosis through activating autophagy.
Wang Y; He X; Wang H; Hu W; Sun L
J Ethnopharmacol; 2024 May; 325():117820. PubMed ID: 38286157
[TBL] [Abstract][Full Text] [Related]
38. Lanatoside C protects mice against bleomycin-induced pulmonary fibrosis through suppression of fibroblast proliferation and differentiation.
Nie Y; Zhang D; Jin Z; Li B; Wang X; Che H; You Y; Qian X; Zhang Y; Zhao P; Chai G
Clin Exp Pharmacol Physiol; 2019 Jun; 46(6):575-586. PubMed ID: 30854687
[TBL] [Abstract][Full Text] [Related]
39. Paroxetine protects against bleomycin-induced pulmonary fibrosis by blocking GRK2/Smad3 pathway.
Zhao K; Nie H; Tang Z; Chen G; Huang J
Aging (Albany NY); 2023 Oct; 15(19):10524-10539. PubMed ID: 37815883
[TBL] [Abstract][Full Text] [Related]
40. Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling.
Hu Y; Wang Q; Yu J; Zhou Q; Deng Y; Liu J; Zhang L; Xu Y; Xiong W; Wang Y
Nat Commun; 2022 Jan; 13(1):114. PubMed ID: 35013220
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]